Press Release Seraxis Announces Publication of Preclinical Data for a Novel Islet Replacement Therapy and Clinical Candidate SR-02 for Insulin-Requiring Diabetes; Oral Presentation at IPITA. admin October 26, 2023
Press Release Seraxis to provide oral update on its pancreatic organoid candidate for functional cure of T1D at the 59th Annual Meeting of the EASD. admin September 28, 2023
Press Release Seraxis announces closing of second VC tranche and successful completion of preclinical studies of pancreatic organoids from Seraxis’ novel pancreas-derived stem cells. admin September 20, 2023
Press Release Late-Breaking Results of a Preclinical Efficacy Study presented at ENDO 2023 show Seraxis SRE Sustainably Reverses Type-1-Diabetes Hyperglycemia. admin July 16, 2023
Press Release Seraxis Presents Successful Results Using Synthetic Replacement Endocrine Clusters for Type 1 Diabetes at the 4th IPITA / HSCI / JDRF Summit. admin April 25, 2023
Press Release Seraxis announces Appointment of Chief Medical Officer, Dr. Paul Strumph. admin August 30, 2022
Publication Cell Replacement Therapy for Insulin-Dependent Diabetes: Maintaining Islet Architecture and Distribution After Graft. admin April 30, 2020
Presentation Concise Review: Lessons Learned from Islet Transplant Clinical Trials in Developing Stem Cell Therapies for Type 1 Diabetes. admin November 12, 2018
Press Release Seraxis Inc. publishes clinical trial considerations for a type 1 diabetes stem cell-derived therapy. admin November 12, 2018
